HIV is preventable, yet new diagnoses continue in AZ at higher-than-average rates. Could a new, twice-yearly shot called Yeztugo change that?

National Institutes of Health Director Dr. Jay Bhattacharya attempted to reassure members of Congress on both sides of the aisle on Tuesday that his biomedical research agency is on the right track.

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Researchers at La Jolla Institute for Immunology, Scripps Research, and the Ragon Institute of MGH, MIT, and Harvard report coordinated studies showing that several HIV germline-targeting immunogens ...

Today, advancements in medicine have rendered HIV a manageable condition that allows most individuals to enjoy a typical ...

New research shows first population-level evidence globally that a national HPV vaccination program can be highly effective ...

A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the ...

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single ...

People living with HIV represent a unique population in the field of infectious disease and immunology due to persistent immune dysregulation and an ...

Scientists designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus. (Nanowerk News) One of the biggest hurdles in developing an HIV ...

Scientists have designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus. One of the biggest hurdles in developing an HIV vaccine is ...